BOLLATI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 140
AS - Asia 63
EU - Europa 55
AF - Africa 1
Totale 259
Nazione #
US - Stati Uniti d'America 139
CN - Cina 28
UA - Ucraina 25
HK - Hong Kong 12
SG - Singapore 12
DE - Germania 8
IN - India 7
FI - Finlandia 4
RU - Federazione Russa 4
TR - Turchia 4
FR - Francia 3
GB - Regno Unito 3
IE - Irlanda 3
IT - Italia 3
BE - Belgio 2
CA - Canada 1
MU - Mauritius 1
Totale 259
Città #
Chandler 22
Jacksonville 20
Ann Arbor 13
Fairfield 12
Hong Kong 12
Singapore 11
Woodbridge 11
Nanjing 8
Houston 7
Ashburn 6
Princeton 6
Cambridge 5
Wilmington 5
Istanbul 4
Nanchang 4
Dublin 3
Moscow 3
Tianjin 3
Boardman 2
Brussels 2
Dearborn 2
Seattle 2
Shenyang 2
Augusta 1
Bangalore 1
Beijing 1
Brescia 1
Changsha 1
Des Moines 1
Hangzhou 1
Hebei 1
Hefei 1
Jiaxing 1
Jinan 1
Los Angeles 1
Milan 1
Norwalk 1
Paris 1
San Francisco 1
Taiyuan 1
Taizhou 1
Toronto 1
Verona 1
Wenzhou 1
Totale 186
Nome #
Somatostatin analogs selective for subtyps 2 and 5 of the somatostatin receptor suppress with different patterns growth hormone (GH) secretion in human GH-secreting adenoma cells cultured in vitro. 92
Inhibitory effects of galanin on growth hormone (GH) release in cultured GH-secreting adenoma cells: comparative study with octreotide, GH-releasing hormone, and thyrotropin-releasing hormone. 74
Effects of LY 117018, a Raloxifene analog, on Growth Hormone GH-Secreting Pituitary Adenoma Cells. 50
Effects of LY 117018, a Raloxifene analog, on 17-beta-estradiolo-induced Growth Hormone (GH) Secretion in Cultured Human GH-Secreting Pituitary Adenoma Cells. 49
Totale 265
Categoria #
all - tutte 1.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202037 0 0 0 0 0 0 9 9 4 9 2 4
2020/202142 1 5 1 4 2 4 1 5 8 3 7 1
2021/202225 1 7 0 2 0 0 2 0 4 1 2 6
2022/202344 5 0 0 4 6 13 0 5 8 0 2 1
2023/202414 3 0 1 0 0 0 0 2 4 0 0 4
2024/202526 0 0 0 4 8 8 6 0 0 0 0 0
Totale 265